Charles Bennett to Time Factors
This is a "connection" page, showing publications Charles Bennett has written about Time Factors.
Connection Strength
0.512
-
Nighttime and weekend medication error rates in an inpatient pediatric population. Ann Pharmacother. 2010 Nov; 44(11):1739-46.
Score: 0.050
-
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J Clin Oncol. 2009 Sep 10; 27(26):4398-405.
Score: 0.046
-
Metastasis of genitourinary tumors to the head and neck region. Eur Arch Otorhinolaryngol. 2010 Feb; 267(2):273-9.
Score: 0.045
-
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res. 2009 Jun 01; 15(11):3850-5.
Score: 0.045
-
Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. 2007 Aug; 40(3):185-92.
Score: 0.039
-
Delays in suspicion and isolation among hospitalized persons with pulmonary tuberculosis at public and private US hospitals during 1996 to 1999. Chest. 2005 Jan; 127(1):205-12.
Score: 0.033
-
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke. 2004 Feb; 35(2):533-7.
Score: 0.031
-
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. J Clin Oncol. 2003 Oct 15; 21(20):3859-66.
Score: 0.031
-
Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology. J Clin Oncol. 1999 Nov; 17(11):3676-81.
Score: 0.023
-
Prostate cancer patients' utilities for health states: how it looks depends on where you stand. Med Decis Making. 1998 Jul-Sep; 18(3):278-86.
Score: 0.021
-
Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med. 1998 Apr 01; 128(7):541-4.
Score: 0.021
-
Health economics in the treatment of colorectal cancer. Cancer Invest. 1998; 16(8):582-7.
Score: 0.020
-
Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions. Transfusion. 2017 08; 57(8):2045-2053.
Score: 0.020
-
Patterns of care for and outcomes of Pneumocystis carinii pneumonia among persons with transfusion-acquired AIDS. Transfusion. 1995 Aug; 35(8):674-8.
Score: 0.017
-
Angiotensin receptor blockers: are they related to lung cancer? J Hypertens. 2013 Aug; 31(8):1669-75.
Score: 0.015
-
Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity. Biosecur Bioterror. 2012 Sep; 10(3):264-79.
Score: 0.014
-
Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009 Jan; 249(1):63-71.
Score: 0.011
-
Development and validation of a short-form, rapid estimate of adult literacy in medicine. Med Care. 2007 Nov; 45(11):1026-33.
Score: 0.010
-
HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care STDS. 2004 Feb; 18(2):99-107.
Score: 0.008
-
Delays in tuberculosis isolation and suspicion among persons hospitalized with HIV-related pneumonia. Chest. 2000 Jan; 117(1):110-6.
Score: 0.006
-
Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995. Bone Marrow Transplant. 1999 Sep; 24(6):679-84.
Score: 0.006